How Investors May Respond To Air Products (APD) Funding Dividends Amid Heavy Hydrogen Spending

Air Products and Chemicals, Inc. +1.42%

Air Products and Chemicals, Inc.

APD

293.55

+1.42%

  • Air Products and Chemicals paid its latest quarterly dividend of US$1.79 per share on February 9, 2026, extending a 44-year streak of annual dividend increases.
  • However, dividend growth has slowed to around 1.1% and the company is relying on financing rather than free cash flow due to heavy hydrogen-related capital spending, raising questions about how long its dividend policy can be maintained on this basis.
  • We’ll now examine how funding dividends through financing amid large hydrogen investments may influence Air Products and Chemicals’ broader investment narrative.

We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Air Products and Chemicals Investment Narrative Recap

To own Air Products and Chemicals today, you need to believe its heavy hydrogen and energy transition spending will eventually turn current cash flow pressure into attractive long term returns. The latest dividend, funded largely through financing rather than free cash flow, does not appear to change the key near term catalyst, which is getting large hydrogen projects closer to cash generation, or the main risk, which is sustained balance sheet strain if those projects take longer or cost more than expected.

The most relevant recent announcement alongside the February dividend is the new US$1.81 quarterly payout declared on January 27, 2026, which extends the 44 year increase streak despite negative free cash flow. That move keeps income focused investors engaged, but it also tightens the link between the success of hydrogen and ammonia projects and the company’s ability to support both its dividend policy and ongoing capital spending without overreliance on external funding.

But investors should also be aware that if large hydrogen projects face delays or overruns, the combination of rising debt and a still growing dividend could...

Air Products and Chemicals' narrative projects $14.9 billion revenue and $3.8 billion earnings by 2028. This requires 7.4% yearly revenue growth and about a $2.2 billion earnings increase from $1.6 billion today.

Uncover how Air Products and Chemicals' forecasts yield a $300.43 fair value, a 7% upside to its current price.

Exploring Other Perspectives

APD 1-Year Stock Price Chart
APD 1-Year Stock Price Chart

Two fair value estimates from the Simply Wall St Community span roughly US$263 to US$300 per share, showing how widely private investor views can differ. Against this, the reliance on financing to fund dividends while hydrogen investments weigh on free cash flow gives you an additional lens on how those differing expectations might play out in the company’s performance over time.

Explore 2 other fair value estimates on Air Products and Chemicals - why the stock might be worth as much as 7% more than the current price!

Build Your Own Air Products and Chemicals Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your Air Products and Chemicals research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.
  • Our free Air Products and Chemicals research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Air Products and Chemicals' overall financial health at a glance.

Want Some Alternatives?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

  • Invest in the nuclear renaissance through our list of 85 elite nuclear energy infrastructure plays powering the global AI revolution.
  • The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 28 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
  • AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.